Clinical Trials · NCT02200991
Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 136
- Start date
- Aug 2014
- Locations
- 20 sites, Japan
- Primary endpoint
- Change from baseline in postprandial plasma glucose at Day 29 after a standardized breakfast